AXIM BIOTECHNOLOGIES, INC. (AXIM) Operating cash flow 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.0MFY2023 · since FY2014: -$338,999 → -$1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$1.0M | +49.6% |
| FY2022 | -$2.0M | +17.8% |
| FY2021 | -$2.5M | +22.7% |
| FY2020 | -$3.2M | +36.2% |
| FY2019 | -$5.0M | -4.0% |
| FY2018 | -$4.8M | -57.2% |
| FY2017 | -$3.1M | -138.1% |
| FY2016 | -$1.3M | +15.9% |
| FY2015 | -$1.5M | -354.0% |
| FY2014 | -$338,999 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Net marginAXIM Gross profitAXIM Gross marginAXIM Operating incomeAXIM Operating marginAXIM Free cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →